RecruitingNCT07603583

Assessment of Heart Rate Variability for Predicting Obstructive Sleep Apnea in Patients With Hypertension

The Exploration of the Relationship Between Hypertension and Sleep Apnea Through Heart Rate Variability, and the Subsequent Investigation of Non-pharmacological and Pharmacological Treatments


Sponsor

Kaohsiung Armed Forces General Hospital

Enrollment

100 participants

Start Date

Apr 30, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to investigate the relationship between hypertension and obstructive sleep apnea (OSA) using heart rate variability (HRV) as a non-invasive biomarker of autonomic nervous system function. Hypertensive patients at high risk for OSA will undergo 24-hour Holter electrocardiogram monitoring to assess HRV parameters, along with overnight polysomnography (PSG) to determine OSA severity. The study will analyze the association between HRV indices and the apnea-hypopnea index (AHI), and develop predictive models using machine learning techniques. In addition, patients diagnosed with OSA will be followed after treatment, and changes in HRV and blood pressure will be evaluated to assess treatment effects and autonomic function recovery. The results of this study may provide a cost-effective and clinically applicable approach for early detection, risk stratification, and management of OSA in patients with hypertension.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Age 18 to 65 years
  • Diagnosed hypertension or resistant hypertension
  • STOP-Bang score ≥3 indicating high risk of obstructive sleep apnea
  • Willing and able to provide informed consent

Exclusion Criteria3

  • Refusal to undergo HRV monitoring or polysomnography
  • Unstable medical condition that may interfere with study participation
  • Inability to comply with study procedures

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTPolysomnography

Overnight polysomnography (PSG) will be performed to evaluate sleep parameters and determine the severity of obstructive sleep apnea.


Locations(1)

Kaohsiung Armed Forces General Hospital

Kaohsiung City, Kaohsiung, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07603583


Related Trials